CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for OPKO Health Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

OPKO Health Inc
4400 Biscayne Blvd.
Phone: (305) 575-4181p:305 575-4181 MIAMI, FL  33137  United States Ticker: OPKOPK

Business Summary
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer PhillipFrost 87 3/27/2007 3/27/2007
President, Vice Chairman of the Board Elias A.Zerhouni 73 5/9/2022 5/9/2022
Vice Chairman of the Board, Chief Technical Officer Jane H.Hsiao 76 5/4/2007 2/1/2007
10 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
OPKO BIOLOGICS LTD. 7 GOLDA MEIR STREET NES ZIONA
OPKO CHILE S.A. AGUSTINAS 460, PISO 10 SANTIAGO CHILE
Ariosa Diagnostics, Inc. 5945 OPTICAL COURT SAN JOSE CA United States
10 additional Subsidiary records available in full report.

Business Names
Business Name
ALS Distribuidora Limitada
Arama Natural Products Distribuidora, Ltda
Ariosa Diagnostics Inc
27 additional Business Names available in full report.

General Information
Number of Employees: 3,930 (As of 12/31/2023)
Outstanding Shares: 696,991,677 (As of 2/13/2024)
Shareholders: 368
Stock Exchange: NASD
Federal Tax Id: 752402409
Email Address: info@cytoclonal.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024